+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Solubility Enhancement Excipients Market - Global Forecast to 2030- Product Image
Solubility Enhancement Excipients Market - Global Forecast to 2030- Product Image
Sale

Solubility Enhancement Excipients Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675273
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Solubility Enhancement Excipients Market grew from USD 3.74 billion in 2024 to USD 3.97 billion in 2025. It is expected to continue growing at a CAGR of 6.31%, reaching USD 5.41 billion by 2030.

The solubility enhancement excipients sector has become indispensable to modern pharmaceutical development, addressing one of the most persistent challenges in drug formulation: the poor aqueous solubility of active pharmaceutical ingredients. As the complexity of molecules in the drug pipeline increases, so does the demand for innovative excipients that can transform insoluble compounds into bioavailable formulations. Beyond pharmaceuticals, applications in nutraceuticals and personal care have broadened the scope of these functional ingredients, reinforcing their strategic importance.

Against a backdrop of tightening quality standards and sustainability imperatives, the industry is undergoing a paradigm shift. Drug developers and excipient suppliers are collaborating more closely than ever to deliver targeted solutions that meet stringent regulatory and performance criteria. This introduction establishes the context for a deeper exploration of the forces reshaping the landscape, the emerging segmentation dynamics, and actionable insights to guide decision-makers in navigating a rapidly evolving market.

Transformative Shifts Driving Innovation and Sustainability

Recent years have witnessed transformative shifts across formulation science and excipient technology. Advanced manufacturing techniques such as hot-melt extrusion and spray drying have democratized access to amorphous solid dispersions, enhancing solubility without compromising stability. Concurrently, the adoption of green chemistry principles is driving the development of bio-based polymers and natural surfactants, reducing the environmental footprint of formulations.

The regulatory environment has also evolved, with agencies emphasizing quality by design (QbD) frameworks that incentivize risk-based excipient selection. Personalized medicine trends are accelerating demand for versatile excipients that can support customized dosage forms, including 3D-printed tablets and patient-specific implants. Taken together, these shifts are compelling manufacturers to invest in agile R&D platforms and strategic partnerships, setting the stage for sustained innovation and competitive differentiation.

Assessing the 2025 United States Tariffs and Strategic Supply Chain Responses

The cumulative impact of recent United States tariffs, introduced in 2025, has created headwinds for excipient manufacturers and downstream formulators alike. Tariffs on key commodity chemicals and specialty lipids have increased input costs, prompting companies to reassess supply chains and sourcing strategies. Many stakeholders have accelerated nearshoring initiatives to mitigate exposure to import duties, even as logistics bottlenecks persist.

In response, leading excipient providers are renegotiating long-term contracts, leveraging vertical integration, and pursuing alternative raw material streams from tariff-exempt regions. The cost pressures have also underscored the importance of formulation efficiency and material sparing: excipients that deliver maximal performance at minimal dosage are now highly prized. Overall, the 2025 tariff landscape has catalyzed a reconfiguration of procurement models, driving both risk mitigation and innovation in sourcing.

Comprehensive Segmentation Insights Shaping Formulation Strategies

Deep segmentation analysis reveals that excipient selection has become increasingly nuanced. In terms of type, the study encompasses a spectrum from Cyclodextrins-spanning alpha-, beta-, and gamma-forms-to hydrophilic polymers including hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG), polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP), as well as lipophilic excipients such as fatty acids, lecithins and surfactants, complemented by solid dispersion agents like maltodextrin, mannitol and sorbitol. Each category offers distinct solubilization mechanisms, enabling formulators to tailor performance profiles to specific API characteristics.

Functionality segmentation further distinguishes excipients by their roles: bioavailability enhancers that facilitate absorption, release modifiers that control dissolution kinetics, solubility enhancers that improve wettability and stabilizers that protect against crystallization and degradation. Route of administration analysis underscores divergent requirements across injectable, oral, topical and transdermal delivery systems, each demanding excipients with precise viscosity, emulsification and compatibility attributes.

Source-based distinctions separate natural excipients-such as plant-derived cyclodextrins-from synthetic analogs engineered for reproducibility and regulatory clarity. Form considerations evaluate liquid versus powder formats, balancing handling efficiency against solubility kinetics. Dosage form insights encompass inhalation, injectable, oral and topical formulations, while application segmentation highlights the excipient needs of pharmaceuticals alongside adjacent markets in cosmetics, personal care and nutraceuticals. Integrating these segmentation layers empowers stakeholders to make informed choices, optimizing both formulation performance and cost-effectiveness.

Key Regional Dynamics and Strategic Growth Drivers

Regional dynamics in the solubility enhancement excipients market reveal distinct opportunity sets. The Americas benefit from a mature biopharmaceutical ecosystem and robust regulatory frameworks, fostering early adoption of advanced excipients and formulation technologies. Investment in contract development and manufacturing organizations (CDMOs) has catalyzed growth, particularly in small molecule and biologics applications.

Across Europe, the Middle East and Africa, stringent quality standards and sustainability mandates are accelerating the uptake of green excipient alternatives and circular supply models. Collaborations between specialty chemical producers and academic research centers are driving ground-breaking polymer innovations. However, price sensitivity in certain markets underscores the need for cost-balanced solutions.

The Asia-Pacific region is emerging as a high-growth frontier, powered by expanding pharmaceutical manufacturing capacity in China and India, rising healthcare expenditures and supportive government initiatives. Local excipient manufacturers are scaling production, while multinational suppliers are forging joint ventures to meet regional demand. Collectively, these regional insights highlight the importance of tailored market entry and growth strategies that account for regulatory, economic and technological factors.

Competitive Landscape and Leading Excipients Providers

The competitive landscape features a diverse array of global and specialized players, each leveraging unique capabilities. ABITEC Corporation and Lubrizol Corporation have distinguished themselves through lipid-based technologies, while Air Liquide S.A. and DuPont de Nemours Inc. integrate excipient offerings into broader chemical portfolios. Ashland Global Holdings Inc. excels in polymer science, and BASF SE continues to advance novel surfactant systems.

Cargill, Incorporated and Roquette Freres SA emphasize plant-derived excipients and functional fibers. Clariant International Ltd. and Croda International PLC prioritize green chemistry and renewable feedstocks. Evonik Industries AG and Merck KGaA are known for high-purity polymers and cyclodextrin complexes. Specialty firms such as FREUND Corporation, Gattefossé and JRS Pharma GmbH & Co. KG deliver targeted solutions for lipid and dispersion technologies.

IMCD Group acts as a key distributor, while Kerry Group PLC and Pharma Excipients International AG focus on co-development partnerships. Nippon Soda Co. Ltd. and Shin-Etsu Chemical Co. Ltd. contribute advanced silicones and siloxane-based excipients. Solvay SA, Spi Pharma Inc. and The Dow Chemical Company offer comprehensive formulation toolkits. FMC Corporation and Wacker Chemie AG round out the roster with performance polymers and silicones. This array of capabilities underscores the importance of strategic alliances, M&A, and continuous innovation to maintain competitive advantage.

Actionable Recommendations for Industry Leaders

Industry leaders must act decisively to capture emerging opportunities and mitigate risks. First, forging strategic partnerships between excipient suppliers, CDMOs and biotech innovators can expedite formulation development and accelerate time to market. Second, investing in sustainable and bio-based excipient platforms will align with regulatory trends and customer preferences, differentiating product portfolios.

Third, supply chain resilience should be strengthened through diversification of raw material sources, nearshoring initiatives and long-term procurement agreements insulated from tariff volatility. Fourth, embracing digital tools-such as predictive modeling, AI-driven formulation design and real-time analytics-will enhance R&D efficiency and quality control. Fifth, targeting high-growth segments like inhalation and transdermal delivery, along with adjacent nutraceutical and personal care markets, can unlock new revenue streams while leveraging core excipient expertise.

By implementing these recommendations, companies can navigate the evolving landscape with agility, ensuring sustained growth and leadership in solubility enhancement technologies.

Conclusion: Navigating Opportunities in Excipients Innovation

In summary, the solubility enhancement excipients market is at a pivotal juncture, driven by technological breakthroughs, evolving regulatory demands and shifting supply chain dynamics. Segmentation analysis underscores a rich landscape of excipient types, functionalities and applications, while regional and competitive insights reveal diverse pathways to growth. As tariffs and sustainability imperatives reshape procurement and innovation strategies, agility and collaboration emerge as critical success factors.

Leaders who align R&D investment with market needs, diversify supply chains and adopt advanced digital capabilities will be best positioned to capitalize on the burgeoning demand for high-performance excipients. By maintaining a customer-centric focus and leveraging cross-sector partnerships, stakeholders can deliver next-generation formulation solutions that meet the highest standards of efficacy, quality and sustainability.

Market Segmentation & Coverage

This research report categorizes the Solubility Enhancement Excipients Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cyclodextrins
    • Alpha-cyclodextrin
    • Beta-cyclodextrin
    • Gamma-cyclodextrin
  • Hydrophilic Polymers
    • Hydroxypropyl methylcellulose (HPMC)
    • PEG (Polyethylene glycol)
    • Polyvinyl alcohol (PVA)
    • PVP (Polyvinylpyrrolidone)
  • Lipophilic Excipients
    • Fatty Acids
    • Lecithins
    • Surfactants
  • Solid Dispersion Agents
    • Maltodextrin
    • Mannitol
    • Sorbitol
  • Surfactants
  • Bioavailability Enhancers
  • Release Modifiers
  • Solubility Enhancers
  • Stabilizers
  • Injectable Drug Delivery
  • Oral Drug Delivery
  • Topical Drug Delivery
  • Transdermal Drug Delivery
  • Natural Excipients
  • Synthetic Excipients
  • Liquid
  • Powder
  • Inhalation Formulation
  • Injectable Formulation
  • Oral Formulation
  • Topical Formulation
  • Cosmetics & Personal Care
  • Nutraceuticals
  • Pharmaceuticals

This research report categorizes the Solubility Enhancement Excipients Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Solubility Enhancement Excipients Market to delves into recent significant developments and analyze trends in each of the following companies:

  • ABITEC Corporation
  • Air Liquide S.A.
  • Ashland Global Holdings Inc.
  • BASF SE
  • Cargill, Incorporated
  • Clariant International Ltd.
  • Croda International PLC
  • DuPont de Nemours Inc.
  • Evonik Industries AG
  • FMC Corporation
  • FREUND Corporation
  • Gattefossé
  • IMCD Group
  • JRS Pharma GmbH & Co. KG
  • Kerry Group PLC
  • Lubrizol Corporation
  • Merck KGaA
  • Nippon Soda Co. Ltd.
  • Pharma Excipients International AG
  • Roquette Freres SA
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay SA
  • SPI Pharma Inc.
  • The DOW Chemical Company
  • Wacker Chemie AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Solubility Enhancement Excipients Market, by Type
8.1. Introduction
8.2. Cyclodextrins
8.2.1. Alpha-cyclodextrin
8.2.2. Beta-cyclodextrin
8.2.3. Gamma-cyclodextrin
8.3. Hydrophilic Polymers
8.3.1. Hydroxypropyl methylcellulose (HPMC)
8.3.2. PEG (Polyethylene glycol)
8.3.3. Polyvinyl alcohol (PVA)
8.3.4. PVP (Polyvinylpyrrolidone)
8.4. Lipophilic Excipients
8.4.1. Fatty Acids
8.4.2. Lecithins
8.4.3. Surfactants
8.5. Solid Dispersion Agents
8.5.1. Maltodextrin
8.5.2. Mannitol
8.5.3. Sorbitol
8.6. Surfactants
9. Solubility Enhancement Excipients Market, by Functionality
9.1. Introduction
9.2. Bioavailability Enhancers
9.3. Release Modifiers
9.4. Solubility Enhancers
9.5. Stabilizers
10. Solubility Enhancement Excipients Market, by Route of Administration
10.1. Introduction
10.2. Injectable Drug Delivery
10.3. Oral Drug Delivery
10.4. Topical Drug Delivery
10.5. Transdermal Drug Delivery
11. Solubility Enhancement Excipients Market, by Source
11.1. Introduction
11.2. Natural Excipients
11.3. Synthetic Excipients
12. Solubility Enhancement Excipients Market, by Form
12.1. Introduction
12.2. Liquid
12.3. Powder
13. Solubility Enhancement Excipients Market, by Dosage Form
13.1. Introduction
13.2. Inhalation Formulation
13.3. Injectable Formulation
13.4. Oral Formulation
13.5. Topical Formulation
14. Solubility Enhancement Excipients Market, by Application
14.1. Introduction
14.2. Cosmetics & Personal Care
14.3. Nutraceuticals
14.4. Pharmaceuticals
15. Americas Solubility Enhancement Excipients Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Solubility Enhancement Excipients Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Solubility Enhancement Excipients Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. ABITEC Corporation
18.3.2. Air Liquide S.A.
18.3.3. Ashland Global Holdings Inc.
18.3.4. BASF SE
18.3.5. Cargill, Incorporated
18.3.6. Clariant International Ltd.
18.3.7. Croda International PLC
18.3.8. DuPont de Nemours Inc.
18.3.9. Evonik Industries AG
18.3.10. FMC Corporation
18.3.11. FREUND Corporation
18.3.12. Gattefossé
18.3.13. IMCD Group
18.3.14. JRS Pharma GmbH & Co. KG
18.3.15. Kerry Group PLC
18.3.16. Lubrizol Corporation
18.3.17. Merck KGaA
18.3.18. Nippon Soda Co. Ltd.
18.3.19. Pharma Excipients International AG
18.3.20. Roquette Freres SA
18.3.21. Shin-Etsu Chemical Co., Ltd.
18.3.22. Solvay SA
18.3.23. SPI Pharma Inc.
18.3.24. The DOW Chemical Company
18.3.25. Wacker Chemie AG
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET MULTI-CURRENCY
FIGURE 2. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET MULTI-LANGUAGE
FIGURE 3. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ALPHA-CYCLODEXTRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY BETA-CYCLODEXTRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY GAMMA-CYCLODEXTRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY PEG (POLYETHYLENE GLYCOL), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY PVP (POLYVINYLPYRROLIDONE), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LECITHINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SURFACTANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY MALTODEXTRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SURFACTANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY BIOAVAILABILITY ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY RELEASE MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLUBILITY ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY INHALATION FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ORAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 90. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 91. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 92. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 93. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 94. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 98. CANADA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 105. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 147. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 148. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 149. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 150. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 151. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 155. CHINA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 158. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 159. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 160. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 161. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 162. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 164. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 165. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 166. INDIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 180. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 181. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 182. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 184. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 186. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 188. JAPAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 243. TAIWAN SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 246. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 247. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 248. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 250. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 252. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 253. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 254. THAILAND SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 278. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 280. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 281. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 282. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 283. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 284. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 286. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 287. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 288. DENMARK SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 290. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY CYCLODEXTRINS, 2018-2030 (USD MILLION)
TABLE 291. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY HYDROPHILIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 292. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY LIPOPHILIC EXCIPIENTS, 2018-2030 (USD MILLION)
TABLE 293. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY SOLID DISPERSION AGENTS, 2018-2030 (USD MILLION)
TABLE 294. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 295. EGYPT SOLUBILITY ENHANCEMENT EXCIPIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLI

Companies Mentioned

  • ABITEC Corporation
  • Air Liquide S.A.
  • Ashland Global Holdings Inc.
  • BASF SE
  • Cargill, Incorporated
  • Clariant International Ltd.
  • Croda International PLC
  • DuPont de Nemours Inc.
  • Evonik Industries AG
  • FMC Corporation
  • FREUND Corporation
  • Gattefossé
  • IMCD Group
  • JRS Pharma GmbH & Co. KG
  • Kerry Group PLC
  • Lubrizol Corporation
  • Merck KGaA
  • Nippon Soda Co. Ltd.
  • Pharma Excipients International AG
  • Roquette Freres SA
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay SA
  • SPI Pharma Inc.
  • The DOW Chemical Company
  • Wacker Chemie AG

Methodology

Loading
LOADING...

Related Topics

Related Reports

2025 Polymer Based Solubility Enhancement Excipients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Polymer Based Solubility Enhancement Excipients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 153 Pages
  • Global
From
2025 Polymer Based Solubility Enhancement Excipients for OSDF Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Polymer Based Solubility Enhancement Excipients for OSDF Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 147 Pages
  • Global
From
Polymer Based Solubility Enhancement Excipient Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Polymer Based Solubility Enhancement Excipient Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Polymer Based Solubility Enhancement Excipient Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Polymer Based Solubility Enhancement Excipient Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 98 Pages
  • Global
From
Solubility Enhancement Excipient Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Solubility Enhancement Excipient Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 103 Pages
  • Global
From

About the Solubility Enhancement Excipient Market

The Solubility Enhancement Excipient market is a subset of the Pharmaceutical Intermediates market. It is composed of excipients, which are inactive ingredients used to improve the solubility of active pharmaceutical ingredients (APIs). These excipients are used to increase the bioavailability of APIs, allowing them to be absorbed more quickly and efficiently by the body. Excipients also help to stabilize APIs, preventing them from degrading or reacting with other substances. The Solubility Enhancement Excipient market is driven by the increasing demand for APIs in the pharmaceutical industry. As the demand for APIs increases, so does the need for excipients to improve their solubility and bioavailability. This has led to an increase in the number of companies offering solubility enhancement excipients. Some of the major players in this market include BASF, Evonik, Roquette, Ashland, and Merck KGaA. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.